Monkeypox Virus Monoclonal Antibody Market Research Report 2025 | Antiviral Monoclonal Antibodies, Infectious Disease Treatment, Immunotherapy, Vaccine Alternatives, Virus-Specific Therapies

The global Monkeypox Virus Monoclonal Antibody market size was valued at USD 1417 million in 2024 and is forecast to a readjusted size of USD 2571 million by 2031 with a CAGR of 9.0% during review period.

Introduction: Monkeypox Virus and the Rise of Monoclonal Antibodies
The global health crisis surrounding the monkeypox virus (mpox) has escalated rapidly, driving an urgent demand for effective therapeutic interventions. As outbreaks spread across regions previously unaffected by the virus, monoclonal antibodies (mAbs) have emerged as a pivotal treatment modality. In 2025, the Monkeypox Virus Monoclonal Antibody Market is anticipated to experience significant growth, fueled by rising infection rates, technological advancements, and increasing government support for research and development. This report provides an in-depth analysis of the market, focusing on the key drivers, innovations, regional dynamics, and strategic considerations that will shape the future of this crucial market.

Key Market Drivers for Monkeypox Monoclonal Antibodies
The monoclonal antibody market targeting monkeypox is driven by several pivotal factors:

• Surge in Global Monkeypox Cases
  The rapid spread of monkeypox globally, including regions like North America and Europe, has raised awareness and urgency for therapeutic solutions. As of early 2025, the number of confirmed cases continues to rise, further emphasizing the need for rapid-response treatments.
• Government and Health Organization Support
  Governments worldwide, especially in high-risk regions like Africa, have increased funding for the development of monoclonal antibodies to fight monkeypox. Emergency funding, along with expedited regulatory pathways, is accelerating the availability of vaccines and therapeutics, including mAb treatments, to curb outbreaks.
• Advancements in Biopharmaceutical Technologies
  The development of monoclonal antibodies for infectious disease treatment has seen significant progress. Innovations in antibody design, production technologies, and delivery systems are enabling more effective and scalable solutions to combat monkeypox infections globally.

Innovation in Monkeypox Monoclonal Antibody Treatments

• Therapeutic Advancements
  Monoclonal antibodies (mAbs) are becoming increasingly crucial in treating monkeypox. These biologics target specific antigens on the virus, preventing viral replication and reducing disease severity. Clinical trials are ongoing to validate the effectiveness of several mAb candidates, with the expectation of early approvals in 2025.
• Combination Therapies with Vaccines
  The role of vaccines such as Jynneos in conjunction with monoclonal antibody treatments is vital in managing outbreaks. The combination approach of preventive vaccines and therapeutic monoclonal antibodies will enhance treatment efficacy, particularly during large-scale outbreaks.
• AI-Driven Drug Development
  Artificial Intelligence is revolutionizing the process of discovering new monoclonal antibodies. AI technologies can quickly analyze viral proteins and predict the most effective antibody candidates, reducing the timeline for drug discovery and expediting their availability during outbreaks.

Regional Market Dynamics: Insights into Key Areas

• Africa: The Epicenter of Monkeypox Outbreaks
  Africa remains the epicenter of monkeypox outbreaks, with several countries in Central and West Africa experiencing high case numbers. Here, monoclonal antibodies are critical to managing the disease and preventing its spread. Localized production, distribution, and affordability will be key to ensuring equitable access to treatments.
• North America and Europe: Advanced Healthcare Markets
  In North America and Europe, mAb therapies are primarily driven by strong healthcare infrastructure, advanced research capabilities, and significant investments in vaccine and drug development. Governments and health organizations in these regions are securing supplies of monoclonal antibodies and vaccines, ensuring quick deployment in the event of an outbreak.
• Asia-Pacific: Focus on Preparedness and Early Detection
  Although Asia-Pacific countries have reported limited cases of monkeypox, there is a growing focus on preparedness, surveillance, and rapid-response mechanisms. Countries like Japan and South Korea are investing in AI-based diagnostics and strengthening their healthcare infrastructure to detect and respond to outbreaks early. The monoclonal antibody market in this region is expected to grow as countries enhance their public health initiatives.

Strategic Considerations for Stakeholders in the Market

• Investment in R&D and Clinical Trials
  To meet the increasing demand for effective treatments, pharmaceutical companies need to continue investing heavily in research and development (R&D). Speeding up clinical trials for monoclonal antibodies and vaccines will be critical in responding to future outbreaks. Collaborations with public health bodies and international organizations will be essential to fast-track the development of these therapies.
• Robust Supply Chain Management
  With the global nature of the monkeypox threat, a robust supply chain for mAb therapies is crucial. Pharmaceutical companies need to address logistical challenges related to the distribution of monoclonal antibodies, particularly in low-resource regions where access to medicines can be limited.
• Regulatory Alignment and Compliance
  Navigating the complex regulatory landscape is crucial for pharmaceutical companies entering the monkeypox monoclonal antibody market. Regulatory agencies like the U.S. FDA and EMA play an essential role in ensuring that these therapies meet safety and efficacy standards. Strategic collaborations with regulatory bodies can help expedite approvals and ensure compliance with global health standards.

Conclusion: Future Outlook for the Monkeypox Virus Monoclonal Antibody Market
The Monkeypox Virus Monoclonal Antibody Market is set to expand significantly in 2025, driven by the growing prevalence of monkeypox cases, government investment, and breakthroughs in medical innovation. The market is witnessing substantial innovation, particularly in monoclonal antibody therapies, which are increasingly seen as the solution to managing outbreaks. By focusing on research, efficient supply chains, and strategic regional partnerships, stakeholders in the healthcare and pharmaceutical sectors can effectively meet the rising demand for these critical therapies.

As the world prepares for potential future outbreaks, the success of monoclonal antibodies in treating monkeypox will serve as a model for managing other emerging infectious diseases. With a clear focus on prevention, innovation, and global collaboration, the market for monoclonal antibodies will play an integral role in global health security and the fight against infectious diseases in the coming years.

   ProteoGenix
   ACROBiosystems
   Creative Diagnostics
   Novus Biologicals, LLC
   Merck Group
   Absolute Antibody
   Creative Biolabs
   Sanyoubio
   Cnpair
   Vazyme
   Sinobiological

   Purity>90%
   Purity>95%
   Others

   Diagnostic Laboratories
   Research and Academic Laboratories
   Pharmaceutical and Biotechnology Companies

North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Chapter 1, to describe Monkeypox Virus Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Monkeypox Virus Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Monkeypox Virus Monoclonal Antibody from 2020 to 2025.
Chapter 3, the Monkeypox Virus Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monkeypox Virus Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Monkeypox Virus Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Monkeypox Virus Monoclonal Antibody.
Chapter 14 and 15, to describe Monkeypox Virus Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Purity>90%
1.3.3 Purity>95%
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diagnostic Laboratories
1.4.3 Research and Academic Laboratories
1.4.4 Pharmaceutical and Biotechnology Companies
1.5 Global Monkeypox Virus Monoclonal Antibody Market Size & Forecast
1.5.1 Global Monkeypox Virus Monoclonal Antibody Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Monkeypox Virus Monoclonal Antibody Sales Quantity (2020-2031)
1.5.3 Global Monkeypox Virus Monoclonal Antibody Average Price (2020-2031)

2 Manufacturers Profiles

2.1 ProteoGenix
2.1.1 ProteoGenix Details
2.1.2 ProteoGenix Major Business
2.1.3 ProteoGenix Monkeypox Virus Monoclonal Antibody Product and Services
2.1.4 ProteoGenix Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ProteoGenix Recent Developments/Updates
2.2 ACROBiosystems
2.2.1 ACROBiosystems Details
2.2.2 ACROBiosystems Major Business
2.2.3 ACROBiosystems Monkeypox Virus Monoclonal Antibody Product and Services
2.2.4 ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 ACROBiosystems Recent Developments/Updates
2.3 Creative Diagnostics
2.3.1 Creative Diagnostics Details
2.3.2 Creative Diagnostics Major Business
2.3.3 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product and Services
2.3.4 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Creative Diagnostics Recent Developments/Updates
2.4 Novus Biologicals, LLC
2.4.1 Novus Biologicals, LLC Details
2.4.2 Novus Biologicals, LLC Major Business
2.4.3 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product and Services
2.4.4 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Novus Biologicals, LLC Recent Developments/Updates
2.5 Merck Group
2.5.1 Merck Group Details
2.5.2 Merck Group Major Business
2.5.3 Merck Group Monkeypox Virus Monoclonal Antibody Product and Services
2.5.4 Merck Group Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Merck Group Recent Developments/Updates
2.6 Absolute Antibody
2.6.1 Absolute Antibody Details
2.6.2 Absolute Antibody Major Business
2.6.3 Absolute Antibody Monkeypox Virus Monoclonal Antibody Product and Services
2.6.4 Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Absolute Antibody Recent Developments/Updates
2.7 Creative Biolabs
2.7.1 Creative Biolabs Details
2.7.2 Creative Biolabs Major Business
2.7.3 Creative Biolabs Monkeypox Virus Monoclonal Antibody Product and Services
2.7.4 Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Creative Biolabs Recent Developments/Updates
2.8 Sanyoubio
2.8.1 Sanyoubio Details
2.8.2 Sanyoubio Major Business
2.8.3 Sanyoubio Monkeypox Virus Monoclonal Antibody Product and Services
2.8.4 Sanyoubio Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Sanyoubio Recent Developments/Updates
2.9 Cnpair
2.9.1 Cnpair Details
2.9.2 Cnpair Major Business
2.9.3 Cnpair Monkeypox Virus Monoclonal Antibody Product and Services
2.9.4 Cnpair Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cnpair Recent Developments/Updates
2.10 Vazyme
2.10.1 Vazyme Details
2.10.2 Vazyme Major Business
2.10.3 Vazyme Monkeypox Virus Monoclonal Antibody Product and Services
2.10.4 Vazyme Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Vazyme Recent Developments/Updates
2.11 Sinobiological
2.11.1 Sinobiological Details
2.11.2 Sinobiological Major Business
2.11.3 Sinobiological Monkeypox Virus Monoclonal Antibody Product and Services
2.11.4 Sinobiological Monkeypox Virus Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Sinobiological Recent Developments/Updates

3 Competitive Environment: Monkeypox Virus Monoclonal Antibody by Manufacturer

3.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Manufacturer (2020-2025)
3.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Manufacturer (2020-2025)
3.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Monkeypox Virus Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Monkeypox Virus Monoclonal Antibody Manufacturer Market Share in 2024
3.4.3 Top 6 Monkeypox Virus Monoclonal Antibody Manufacturer Market Share in 2024
3.5 Monkeypox Virus Monoclonal Antibody Market: Overall Company Footprint Analysis
3.5.1 Monkeypox Virus Monoclonal Antibody Market: Region Footprint
3.5.2 Monkeypox Virus Monoclonal Antibody Market: Company Product Type Footprint
3.5.3 Monkeypox Virus Monoclonal Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Monkeypox Virus Monoclonal Antibody Market Size by Region
4.1.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2020-2031)
4.1.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2020-2031)
4.1.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Region (2020-2031)
4.2 North America Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031)
4.3 Europe Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031)
4.4 Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031)
4.5 South America Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031)
4.6 Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
5.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type (2020-2031)
5.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
6.2 Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application (2020-2031)
6.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Application (2020-2031)

7 North America

7.1 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
7.2 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
7.3 North America Monkeypox Virus Monoclonal Antibody Market Size by Country
7.3.1 North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2031)
7.3.2 North America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
8.2 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
8.3 Europe Monkeypox Virus Monoclonal Antibody Market Size by Country
8.3.1 Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2031)
8.3.2 Europe Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Monkeypox Virus Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
10.2 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
10.3 South America Monkeypox Virus Monoclonal Antibody Market Size by Country
10.3.1 South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2031)
10.3.2 South America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Monkeypox Virus Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Monkeypox Virus Monoclonal Antibody Market Drivers
12.2 Monkeypox Virus Monoclonal Antibody Market Restraints
12.3 Monkeypox Virus Monoclonal Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Monkeypox Virus Monoclonal Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of Monkeypox Virus Monoclonal Antibody
13.3 Monkeypox Virus Monoclonal Antibody Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Monkeypox Virus Monoclonal Antibody Typical Distributors
14.3 Monkeypox Virus Monoclonal Antibody Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables

Table 1. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ProteoGenix Basic Information, Manufacturing Base and Competitors
Table 4. ProteoGenix Major Business
Table 5. ProteoGenix Monkeypox Virus Monoclonal Antibody Product and Services
Table 6. ProteoGenix Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ProteoGenix Recent Developments/Updates
Table 8. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 9. ACROBiosystems Major Business
Table 10. ACROBiosystems Monkeypox Virus Monoclonal Antibody Product and Services
Table 11. ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. ACROBiosystems Recent Developments/Updates
Table 13. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 14. Creative Diagnostics Major Business
Table 15. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product and Services
Table 16. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Creative Diagnostics Recent Developments/Updates
Table 18. Novus Biologicals, LLC Basic Information, Manufacturing Base and Competitors
Table 19. Novus Biologicals, LLC Major Business
Table 20. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product and Services
Table 21. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Novus Biologicals, LLC Recent Developments/Updates
Table 23. Merck Group Basic Information, Manufacturing Base and Competitors
Table 24. Merck Group Major Business
Table 25. Merck Group Monkeypox Virus Monoclonal Antibody Product and Services
Table 26. Merck Group Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Merck Group Recent Developments/Updates
Table 28. Absolute Antibody Basic Information, Manufacturing Base and Competitors
Table 29. Absolute Antibody Major Business
Table 30. Absolute Antibody Monkeypox Virus Monoclonal Antibody Product and Services
Table 31. Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Absolute Antibody Recent Developments/Updates
Table 33. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 34. Creative Biolabs Major Business
Table 35. Creative Biolabs Monkeypox Virus Monoclonal Antibody Product and Services
Table 36. Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Creative Biolabs Recent Developments/Updates
Table 38. Sanyoubio Basic Information, Manufacturing Base and Competitors
Table 39. Sanyoubio Major Business
Table 40. Sanyoubio Monkeypox Virus Monoclonal Antibody Product and Services
Table 41. Sanyoubio Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Sanyoubio Recent Developments/Updates
Table 43. Cnpair Basic Information, Manufacturing Base and Competitors
Table 44. Cnpair Major Business
Table 45. Cnpair Monkeypox Virus Monoclonal Antibody Product and Services
Table 46. Cnpair Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Cnpair Recent Developments/Updates
Table 48. Vazyme Basic Information, Manufacturing Base and Competitors
Table 49. Vazyme Major Business
Table 50. Vazyme Monkeypox Virus Monoclonal Antibody Product and Services
Table 51. Vazyme Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Vazyme Recent Developments/Updates
Table 53. Sinobiological Basic Information, Manufacturing Base and Competitors
Table 54. Sinobiological Major Business
Table 55. Sinobiological Monkeypox Virus Monoclonal Antibody Product and Services
Table 56. Sinobiological Monkeypox Virus Monoclonal Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Sinobiological Recent Developments/Updates
Table 58. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Manufacturer (2020-2025) & (L)
Table 59. Global Monkeypox Virus Monoclonal Antibody Revenue by Manufacturer (2020-2025) & (USD Million)
Table 60. Global Monkeypox Virus Monoclonal Antibody Average Price by Manufacturer (2020-2025) & (US$/L)
Table 61. Market Position of Manufacturers in Monkeypox Virus Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 62. Head Office and Monkeypox Virus Monoclonal Antibody Production Site of Key Manufacturer
Table 63. Monkeypox Virus Monoclonal Antibody Market: Company Product Type Footprint
Table 64. Monkeypox Virus Monoclonal Antibody Market: Company Product Application Footprint
Table 65. Monkeypox Virus Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 66. Monkeypox Virus Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 68. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2020-2025) & (L)
Table 69. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2026-2031) & (L)
Table 70. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2020-2025) & (USD Million)
Table 71. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2026-2031) & (USD Million)
Table 72. Global Monkeypox Virus Monoclonal Antibody Average Price by Region (2020-2025) & (US$/L)
Table 73. Global Monkeypox Virus Monoclonal Antibody Average Price by Region (2026-2031) & (US$/L)
Table 74. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 75. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 76. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type (2020-2025) & (USD Million)
Table 77. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Type (2026-2031) & (USD Million)
Table 78. Global Monkeypox Virus Monoclonal Antibody Average Price by Type (2020-2025) & (US$/L)
Table 79. Global Monkeypox Virus Monoclonal Antibody Average Price by Type (2026-2031) & (US$/L)
Table 80. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 81. Global Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 82. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Global Monkeypox Virus Monoclonal Antibody Average Price by Application (2020-2025) & (US$/L)
Table 85. Global Monkeypox Virus Monoclonal Antibody Average Price by Application (2026-2031) & (US$/L)
Table 86. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 87. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 88. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 89. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 90. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2025) & (L)
Table 91. North America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2026-2031) & (L)
Table 92. North America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 95. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 96. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 97. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 98. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2025) & (L)
Table 99. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2026-2031) & (L)
Table 100. Europe Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2025) & (USD Million)
Table 101. Europe Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 103. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 104. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 105. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 106. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2020-2025) & (L)
Table 107. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity by Region (2026-2031) & (L)
Table 108. Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2020-2025) & (USD Million)
Table 109. Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value by Region (2026-2031) & (USD Million)
Table 110. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 111. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 112. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 113. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 114. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2025) & (L)
Table 115. South America Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2026-2031) & (L)
Table 116. South America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2025) & (USD Million)
Table 117. South America Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2020-2025) & (L)
Table 119. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Type (2026-2031) & (L)
Table 120. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2020-2025) & (L)
Table 121. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Application (2026-2031) & (L)
Table 122. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2020-2025) & (L)
Table 123. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity by Country (2026-2031) & (L)
Table 124. Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2020-2025) & (USD Million)
Table 125. Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value by Country (2026-2031) & (USD Million)
Table 126. Monkeypox Virus Monoclonal Antibody Raw Material
Table 127. Key Manufacturers of Monkeypox Virus Monoclonal Antibody Raw Materials
Table 128. Monkeypox Virus Monoclonal Antibody Typical Distributors
Table 129. Monkeypox Virus Monoclonal Antibody Typical Customers

List of Figures

Figure 1. Monkeypox Virus Monoclonal Antibody Picture
Figure 2. Global Monkeypox Virus Monoclonal Antibody Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type in 2024
Figure 4. Purity>90% Examples
Figure 5. Purity>95% Examples
Figure 6. Others Examples
Figure 7. Global Monkeypox Virus Monoclonal Antibody Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application in 2024
Figure 9. Diagnostic Laboratories Examples
Figure 10. Research and Academic Laboratories Examples
Figure 11. Pharmaceutical and Biotechnology Companies Examples
Figure 12. Global Monkeypox Virus Monoclonal Antibody Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Monkeypox Virus Monoclonal Antibody Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Monkeypox Virus Monoclonal Antibody Sales Quantity (2020-2031) & (L)
Figure 15. Global Monkeypox Virus Monoclonal Antibody Price (2020-2031) & (US$/L)
Figure 16. Global Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Monkeypox Virus Monoclonal Antibody by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Monkeypox Virus Monoclonal Antibody Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Monkeypox Virus Monoclonal Antibody Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Monkeypox Virus Monoclonal Antibody Average Price by Type (2020-2031) & (US$/L)
Figure 31. Global Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2020-2031)
Figure 33. Global Monkeypox Virus Monoclonal Antibody Average Price by Application (2020-2031) & (US$/L)
Figure 34. North America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 46. France Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Region (2020-2031)
Figure 54. China Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 57. India Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Monkeypox Virus Monoclonal Antibody Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Monkeypox Virus Monoclonal Antibody Consumption Value (2020-2031) & (USD Million)
Figure 74. Monkeypox Virus Monoclonal Antibody Market Drivers
Figure 75. Monkeypox Virus Monoclonal Antibody Market Restraints
Figure 76. Monkeypox Virus Monoclonal Antibody Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Monkeypox Virus Monoclonal Antibody in 2024
Figure 79. Manufacturing Process Analysis of Monkeypox Virus Monoclonal Antibody
Figure 80. Monkeypox Virus Monoclonal Antibody Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source